Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Cash from Operations (2018 - 2025)

TransMedics has reported Cash from Operations over the past 8 years, most recently at 34513000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 34513000.0 for Q4 2025, up 75.52% from a year ago — trailing twelve months through Dec 2025 was 192840000.0 (up 295.14% YoY), and the annual figure for FY2025 was 192840000.0, up 295.14%.
  • Cash from Operations for Q4 2025 was 34513000.0 at TransMedics, down from 69573000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for TMDX hit a ceiling of 91609000.0 in Q2 2025 and a floor of 18406000.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 4785500.0 (2021), compared with a mean of 7696700.0.
  • Biggest five-year swings in Cash from Operations: crashed 151.11% in 2022 and later skyrocketed 914.63% in 2025.
  • TransMedics' Cash from Operations stood at 6648000.0 in 2021, then skyrocketed by 39.31% to 4035000.0 in 2022, then skyrocketed by 305.8% to 8304000.0 in 2023, then skyrocketed by 136.79% to 19663000.0 in 2024, then surged by 75.52% to 34513000.0 in 2025.
  • The last three reported values for Cash from Operations were 34513000.0 (Q4 2025), 69573000.0 (Q3 2025), and 91609000.0 (Q2 2025) per Business Quant data.